Eccrine hidrocystomahttps://en.wikipedia.org/wiki/Hidrocystoma
Eccrine hidrocystoma ke lihlahala tse sa kotsi tse tsoang ho matšoao a mofufutso. Hangata li mpefatsoa ke tikoloho e chesang le e mongobo. Maqeba a hangata a kholo ka lehlabula mme a nyane ka mariha. Maqeba a hlaha joalo ka li‑papules tse bopehileng joaloka letlalo, tse lebelletsoeng sebakeng sa periorbital, hangata haufi le mahlabane a tlase a mahlo.

○ Kalafo
Ho pholisa sebaka se amehileng ho ka fokotsa boholo ba sebaka se amehileng ka nakoana.
Kalafo ea laser hangata ha e sebetse.

☆ AI Dermatology — Free Service
Liphethong tsa 2022 Stiftung Warentest tse tsoang Jeremane, khotsofalo ea bareki ka ModelDerm e ne e le tlase hanyane ho feta lipuisano tse lefelloang tsa telemedicine.
  • E fana ka li-papules tse nyenyane tse putsoa tse tletseng mokelikeli o hlakileng.
    References Eccrine Hidrocystoma: A Report of Two Cases with Special Reference to Dermoscopic Features 34084021 
    NIH
    Eccrine hidrocystomas (EHs) ke lihahlala tse se nang kotsi tse hlahang mekhoeng ea mofufutso ea eccrine. Hangata li tšoaetsoa ke maemo a chesho le mocheso, ’me li hōla ka boholo nakong ea lehlabula ebe li nyenyane nakong ea mariha. Li hlaha e le li‑papule tse nang le mmala oa letlalo, tse lephuthelo, sebakeng se potileng sa leihlo, hangata ho pota lehlakoreng le tlase la leihlo. Biopsy ea letlalo e ka netefatsa diagnosis. Re hlahisa linyeoe tse peli tsa EH, re shebane le likarolo tsa bona tsa dermoscopic le kalafo e atlehileng ka peptide e tšoanang le botulinum toxin‑like peptide.
    Eccrine hidrocystomas (EHs) are benign tumors, which arise as cystic dilatation of the eccrine sweat duct. The lesions of EH have a chronic course with periodic flares in summer months, associated with exacerbation in sweating. Diagnosis is mainly clinical with histopathology being confirmatory. Dermoscopy is a noninvasive tool, which may confirm diagnosis of EH without subjecting the patient to a biopsy. We report two representative cases of EH, with emphasis on dermoscopic features and which well responded to topical botulinum toxin-like peptide.